BLBD
Blue Bird Corporation
BLBD has the edge over TSLA overall, supported by stronger valuation and stronger fundamentals.
TSLA
Tesla, Inc.
TSLA's outlook is improving, though it still trails on the overall score.
BLBD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
BLBD's revenue, profitability, cash flow and balance sheet are all currently healthy.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
BLBD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 6.8x | $55.45 | — |
| Cheap | 13x | $103 | +85% |
| Forward | 13x | $55.45 | — |
| Fair | 17x | $138 | +150% |
| Expensive | 39x | $320 | +476% |
Historical ranges are pointers, not guarantees.
BLBD has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
BLBD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect BLBD's revenue to grow, but its profitability to weaken.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
TSLA has the edge over BLBD on the outlook, with more favorable valuation and earnings expectations.
BLBD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.42 | -46% |
| Q2 2026 | $8.22 | +136% |
| Q1 2026 | $4.07 | +27% |
| Q4 2025 | $3.96 | +23% |
| Q3 2025 | $3.88 | +23% |
| Q2 2025 | $3.48 | +15% |
| Q1 2025 | $3.21 | +30% |
| Q4 2024 | $3.21 | +69% |
| Q3 2024 | $3.16 | +327% |
BLBD has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
BLBD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $517.2M | +30% |
| Q1 2026 | $352.6M | -1.7% |
| Q4 2025 | $333.1M | +6.1% |
| Q3 2025 | $409.4M | +17% |
| Q2 2025 | $398M | +19% |
| Q1 2025 | $358.9M | +3.7% |
| Q4 2024 | $313.9M | -1.2% |
| Q3 2024 | $350.2M | +16% |
BLBD has the edge over TSLA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 12% | -0.5 points |
| Q1 2026 | 11% | +1.7 points |
| Q4 2025 | 11% | +0.8 points |
| Q3 2025 | 12% | +5 points |
| Q2 2025 | 13% | +0.7 points |
| Q1 2025 | 9.4% | -1 points |
| Q4 2024 | 11% | -1.4 points |
| Q3 2024 | 7.3% | -2.3 points |
BLBD has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
BLBD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $21.7M | -59% |
| Q1 2026 | $39.9M | +113% |
| Q4 2025 | $31.1M | +43% |
| Q3 2025 | $60.5M | +20% |
| Q2 2025 | $52.3M | +$55.8M |
| Q1 2025 | $18.7M | -64% |
| Q4 2024 | $21.8M | +$24.5M |
| Q3 2024 | $50.2M | +49% |
BLBD has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
BLBD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +8.4% | +2.7M shares |
| 1 year | +7.9% | +2.6M shares |
| 3 years | +7.8% | +2.6M shares |
| 5 years | +28% | +7.7M shares |
| Available history | +30% | +8.1M shares |
BLBD has 35M diluted shares, up 7.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | $198,000 |
| Q4 2025 | $2.4M |
| Q3 2025 | $5.5M |
| Q2 2025 | — |
| Q1 2025 | $3M |
| Q4 2024 | $1.4M |
| Q3 2024 | $877,000 |
BLBD spent $8M buying back its own shares over the past year, up 52% from the year before.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has the edge over BLBD on shareholder dilution, with a more favorable share count trend.
BLBD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -0.8x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
| Q3 2024 | -0.2x | Net Cash |
BLBD has more cash than debt.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over BLBD on leverage, with a lower net debt burden relative to earnings.
BLBD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.4 | Neutral |
| Stochastic | 8.2 | Oversold |
BLBD's weekly RSI is 39 (neutral) and its Stochastic is 8 (oversold).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
BLBD PE vs Consumer Cyclical Sector
| Metric | BLBD | Sector median | Relative |
|---|---|---|---|
| PE | 6.8x | 18x | 63% below |
| PE % | 0 | 47 | 47 pts below |
BLBD has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
BLBD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.9 | 2.6% below |
| 20 week MA | $63.9 | 13% below |
| 50 week MA | $61.2 | 9.4% below |
| 100 week MA | $52.7 | 5.1% above |
| 200 week MA | $42.1 | 32% above |
BLBD has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 32% above its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over BLBD on trend strength, trading above more of its moving averages.
BLBD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.0 | $19.1 | -17% |
| 2021 | $19.1 | $14.7 | -23% |
| 2022 | $14.7 | $9.97 | -32% |
| 2023 | $9.97 | $27.0 | +170% |
| 2024 | $27.0 | $39.4 | +46% |
| 2025 | $39.4 | $50.7 | +29% |
| 2026 YTD | $50.7 | $55.5 | +9.3% |
BLBD has the edge over TSLA on returns for 2026, with the stronger performance.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA's yearly returns have swung widely, from +669% in 2020 to −65% in 2022. It's down 16% so far in 2026.